IL102137A - History of benzodioxane - Google Patents

History of benzodioxane

Info

Publication number
IL102137A
IL102137A IL10213792A IL10213792A IL102137A IL 102137 A IL102137 A IL 102137A IL 10213792 A IL10213792 A IL 10213792A IL 10213792 A IL10213792 A IL 10213792A IL 102137 A IL102137 A IL 102137A
Authority
IL
Israel
Prior art keywords
carbon atoms
benzodioxin
dihydro
mmole
compound
Prior art date
Application number
IL10213792A
Other languages
English (en)
Hebrew (he)
Other versions
IL102137A0 (en
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/719,887 external-priority patent/US5126366A/en
Priority claimed from US07/719,882 external-priority patent/US5166367A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL102137A0 publication Critical patent/IL102137A0/xx
Publication of IL102137A publication Critical patent/IL102137A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Insulators (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Organic Insulating Materials (AREA)
  • Light Receiving Elements (AREA)
IL10213792A 1991-06-21 1992-06-09 History of benzodioxane IL102137A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/719,887 US5126366A (en) 1991-06-21 1991-06-21 Aminophenoxyalkyl derivatives of benzodioxan
US07/719,882 US5166367A (en) 1991-06-21 1991-06-21 Antipsychotic benzodioxan derivatives

Publications (2)

Publication Number Publication Date
IL102137A0 IL102137A0 (en) 1993-01-14
IL102137A true IL102137A (en) 1996-07-23

Family

ID=27110156

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10213792A IL102137A (en) 1991-06-21 1992-06-09 History of benzodioxane

Country Status (19)

Country Link
EP (1) EP0520674B1 (fr)
JP (1) JP3095533B2 (fr)
KR (1) KR930000496A (fr)
AT (1) ATE126515T1 (fr)
AU (1) AU644743B2 (fr)
BR (1) BR9202321A (fr)
CZ (1) CZ281049B6 (fr)
DE (1) DE69204117T2 (fr)
DK (1) DK0520674T3 (fr)
ES (1) ES2076691T3 (fr)
FI (1) FI922880A (fr)
GR (1) GR3018111T3 (fr)
HU (1) HUT61739A (fr)
IL (1) IL102137A (fr)
MX (1) MX9203109A (fr)
NZ (1) NZ243194A (fr)
PH (1) PH30817A (fr)
RU (1) RU2056417C1 (fr)
TW (1) TW203047B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
KR102021281B1 (ko) * 2018-05-25 2019-09-16 한국 한의학 연구원 프락신을 유효성분으로 포함하는 우울증 및 불안장애 예방, 개선 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1096301A (en) * 1963-06-20 1967-12-29 Ward Blenkinsop & Co Ltd 1,4-benzodioxane derivatives
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents

Also Published As

Publication number Publication date
DE69204117T2 (de) 1996-03-14
AU644743B2 (en) 1993-12-16
PH30817A (en) 1997-10-17
EP0520674B1 (fr) 1995-08-16
GR3018111T3 (en) 1996-02-29
BR9202321A (pt) 1993-01-19
JP3095533B2 (ja) 2000-10-03
ATE126515T1 (de) 1995-09-15
IL102137A0 (en) 1993-01-14
RU2056417C1 (ru) 1996-03-20
CZ281049B6 (cs) 1996-06-12
EP0520674A1 (fr) 1992-12-30
ES2076691T3 (es) 1995-11-01
FI922880A (fi) 1992-12-22
KR930000496A (ko) 1993-01-15
CZ182392A3 (en) 1993-01-13
HU9202060D0 (en) 1992-09-28
DK0520674T3 (da) 1996-01-08
DE69204117D1 (de) 1995-09-21
HUT61739A (en) 1993-03-01
NZ243194A (en) 1993-10-26
FI922880A0 (fi) 1992-06-18
AU1842692A (en) 1992-12-24
MX9203109A (es) 1993-06-01
JPH05194481A (ja) 1993-08-03
TW203047B (fr) 1993-04-01

Similar Documents

Publication Publication Date Title
EP1375503B1 (fr) Dérivés dioxino et leur utilisation comme agonistes de la dopamine
EP1381600A1 (fr) Derives azaheterocyclylmethyle antidepresseurs de 2,3-dihydro-1,4-benzodioxane
IL124095A (en) History of indolealkyl of benzodioxanomethylamine
US5126366A (en) Aminophenoxyalkyl derivatives of benzodioxan
US5166367A (en) Antipsychotic benzodioxan derivatives
US5245051A (en) Antipsychotic chroman derivatives of benzodioxanmethylamine
US5189171A (en) Antipsychotic benzodioxan derivatives
US5134140A (en) Psychotropic benzofuran derivatives
US5235055A (en) Antipsychotic quinoline derivatives of benzodioxanmethylamine
EP0520674B1 (fr) Dérivés du benzodioxanne antipsychotiques
US6800641B2 (en) Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
US6800648B2 (en) Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
IE67793B1 (en) Antipsychotic benzodioxan derivatives
US20030045526A1 (en) Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
US6803368B2 (en) Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene
US20030236241A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void